GSDMD and triple-A syndrome: Thus, regardless of the mechanisms by which disulfiram attenuated experimental AAAs, our findings together with those from other recent studies suggest that pharmacologically inhibiting gasdermin D may have the translational application for limiting clinical AAA progression.